Latest stock research reports with share price targets forecast, buy, hold, and sell recommendations along with upside. Search by company or broker name.
Consolidated EBITDA grew 30.9% YoY to Rs. 7,115cr, with EBITDA margin expanding 210bps to 15.8%, on the back of a favourable product mix and reduced operating costs due to improved operational efficiencies. Profit after tax increased more than fourfold to Rs. 1,646cr, aided by topline growth and an 64% YoY increase in other operating income. JSW Steel reported a strong performance in the quarter despite global uncertainties and a prolonged monsoon. The company is optimistic about a strong performance in the second half of this financial year, driven by rising steel prices and production. JSW has ramped up its production capacity, which is expected to support growth. The outlook for India's steel consumption remains robust, driven by supportive...
Q2FY26 performance: L&T secured robust order inflows (OI) of 115784 crore up 45% YoY and up 23% QoQ, led by energy business which formed 35% of OI. The current order backlog (OB) stands at 667,047 crore up 31% YoY (49% international). Strong execution in the Energy Projects and Hi-tech manufacturing (revenues up 48% and 34% YoY) led to consolidated revenue growing by 10% YoY to 67984 crore for Q2FY26. Consolidated EBITDA grew 10% YoY to 6806 crore and EBITDA Margins came in at 10% down 30 bps YoY due to margin compression in IT & TS segment and energy projects. Consequently, PAT came in at 3926 crore up 16% YoY. On strong customer collection, the NWC ratio to sales improved significantly (200...
*over or under performance to benchmark index Reliance Industries Ltd (RIL) manufactures petrochemicals, synthetic fibres, fibre intermediates, textiles, blended yarns and polyester staple fibres. Its petroleum refinery-cum-petrochemicals complex in Jamnagar, Gujarat, produces gasoline, superior kerosene oil and liquefied petroleum gas, among other products....
Although the company continues to strengthen its presence through new launches, portfolio expansion, and biosimilar development, persistent pricing pressure in the U.S. generics business and adverse product mix are expected to remain key headwinds to its overall profitability.
Marred by extended monsoons coal-based thermal power generation touched a ~30-mth low of 99.29GW in Sep’25, dampening the thermal coal off-take volume.
The management said that NIM is expected to bottom out by Q3FY26, assuming there are no further rate cuts and the balance sheet mix improves. businesses. The management guided that margin is likely to bottom out in the coming quarters as anticipated repo rate cuts exert near-term yield pressure. The bank is focused execution excellence, expanding its distribution network across 2,740 branches and accelerating digital transformation through pioneering agentic AI-powered payment solution for UPI and multiple CBDC initiatives. Company's management is focused on its GPS strategy for building a resilient franchise....
The company showcased strong strategic progress, marked by record deal wins, healthy client expansion, and increasing enterprise adoption of its proprietary AI and digital platforms. Growing traction in the modernisation programmes, deepened technology partnerships and consistent execution across key verticals highlight its strengthening market position. Management maintains growth and margin guidance, reflecting confidence in the demand environment, a scalable innovation pipeline and...
Infosys delivered a steady performance driven by resilience in deal execution, continued traction in digital transformation projects and operational discipline across key verticals. Its focus on GenAI adoption, platform monetisation and cloud-led modernisation is expected to enhance scalability and differentiation. Strategic acquisitions in cybersecurity and consulting strengthen domain capabilities and regional presence, while internal efficiency initiatives and talent upskilling support...
Tata Steel (TATA) is aggressively expanding its capacity in India to capitalize on rising domestic demand, targeting an increase from 26.5mtpa in FY25 to 40mtpa by FY30.
About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Nailing the LCC model, IndiGo managed to capture its home market achieving ~64.4% share, supported by a fleet of ~416 aircraft and an orderbook of ~910 aircraft.
Kotak delivered broadly a steady performance with balanced growth and profitability. Core metrics improved, supported by healthy loan and deposit growth and asset quality gains.
The 2QFY26 margin performance of Dr Reddy’s was marginally weaker than our expectations (in line with street estimates; adjusted for one-offs), with the gross margin (GM) decline being sharper than our expectations (at 55%, GM logged at its lowest since the launch of gRevlimid) and largely a consequence of lower-than-expected gRevlimid sales.
SBI Life has been able to maintain its mid-teen growth guidance in volume and healthy 26–28% VNB margin guidance despite the adverse GST impact on costs.
Kotak Mahindra Bank (KMB) reported in-line Q2FY26 PAT of INR 32.5bn as muted other income (treasury loss) was offset by tight opex control. RoA stood strong at 1.9%.
